High-flying Hologic splits stock

Bone densitometry firm Hologic of Waltham, MA, announced a two-for-one

stock split effective March 25. Hologic's share price has risen

steadily since last year, when Merck received marketing approval

for its Fosamax osteoporosis drug, and the split will make the

company's stock more affordable. Hologic's stock was trading at

around $50 a share the week before the split. It had been trading

at around $14 a share last March (SCAN 12/27/95).